Product Program year 2024 Source: CMS Open Payments

VenaCure 1470 Pro

Device Et

PDI 08033945938925

Open in the dashboard

General payments

$4,116,299

1,894 payments

Research payments

$0

0 payments

Through program year 2024, $4,116,299 in general payments and $0 in research payments were reported against VenaCure 1470 Pro (Et).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $1,280,427 456
2023 General $1,095,520 405
2022 General $881,547 311
2021 General $858,805 722

Breakdown

Who paid General payments · program years 2021–2024
  1. AngioDynamics, Inc. $4,116,299 1,894 payments
Top recipients General payments · program year 2024
  1. Andrew Surmak Surgery · Saint Louis Park, MN $38,400 3% · 8 payments
  2. Kamran Goudarzi Surgery · Wilmington, NC $27,133 2% · 6 payments
  3. Sam Ebrahimi Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tarzana, CA $24,000 2% · 5 payments
  4. Carlton Randleman Thoracic Surgery (Cardiothoracic Vascular Surgery) · Birmingham, AL $24,000 2% · 5 payments
  5. Ron Mark Diagnostic Radiology · Deer Park, NY $24,000 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Surgery $198,382 18% · 25 practitioners
  2. Vascular Surgery Surgery $161,603 14% · 52 practitioners
  3. Vascular & Interventional Radiology Radiology $133,207 12% · 36 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $99,387 9% · 12 practitioners
  5. Cardiovascular Disease Internal Medicine $91,587 8% · 21 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $166,140 13% · 24 recipients
  2. Texas $165,253 13% · 26 recipients
  3. Illinois $128,560 10% · 17 recipients
  4. Florida $122,173 10% · 50 recipients
  5. California $109,107 9% · 27 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,894 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record